News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Razelle Kurzrock: Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience
Razelle Kurzrock/froedtert.com
Jan 21, 2025, 15:31

Razelle Kurzrock: Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience

Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, shared an article by Young Kwang Chae on X:

“Nivo/ipi is active in BAC. Some responses last for years.”

 Razelle Kurzrock: Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma).

Authors: Young Kwang Chae, et al.

Razelle Kurzrock: Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience

 

 

 

 

Adenocarcinoma cancer clinical research CTLA fight against cancer Global fight against cancer OncoDaily Oncology Razelle Kurzrock Wisconsin Cancer Center Young Kwang Chae
Special Coverage
Science
Jan 21, 2025, 15:32
Mohammad Jad Moussa: What drives post-surgical relapse in SCNEC of the Urinary Tract
Blog
Jan 21, 2025, 15:31
Vivek Subbiah: Delighted to work with an amazing crew at Sarah Cannon Research Institute
Blog
Jan 21, 2025, 15:31
Advancing Cancer Care with Lifestyle Medicine
Blog
Jan 21, 2025, 15:31
Agora 2025: ESTRO Future Leaders Retreat
Blog
Jan 21, 2025, 15:31
The transformative role of imaging biomarkers in radiation oncology in this ESTRO Physics Workshop 2024 Report
Blog
Jan 21, 2025, 15:31
Highlighting some of the many amazing organizations standing with us - Florez Lab
Career
Jan 21, 2025, 15:31
Diane Reidy-Lagunes: Honored to join the Duke University Department of Medicine and Health System
Blog
Jan 21, 2025, 15:31
Yale’s Post-SABCS CME webinar series is starting on January 30th
Science
Jan 21, 2025, 15:31
Senthil Kumar: First-Line Treatment in Advanced Endometrial Carcinoma
Blog
Jan 21, 2025, 15:31
César Serrano García: mTOR and PI3K inhibitors can be an effective treatment in GIST SDH-deficient
Blog
Jan 21, 2025, 15:31
Nicole Stout: Implementing navigation programs into cancer care
Insight
Jan 21, 2025, 15:31
FDA Revoked Authorization for the Use of Red No.3 in Food and Ingested Drugs